LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle

Early diagnosis of lung cancer greatly reduces mortality; however, the lack of suitable plasma biomarkers presents a major obstacle. Recent studies showed that long noncoding RNAs (lncRNAs) played important roles in cancer initiation and development. Here, we identified differentially expressed lncR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huange, Zhang, Liyi, Yan, Shi, Li, Wenmei, Cui, Jiantao, Zhu, Min, Xia, Nan, Yang, Yue, Yuan, Jiao, Chen, Xiaowei, Luo, Jianjun, Chen, Runsheng, Xing, Rui, Lu, Youyong, Wu, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352366/
https://www.ncbi.nlm.nih.gov/pubmed/27999202
http://dx.doi.org/10.18632/oncotarget.13980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352366/
https://www.ncbi.nlm.nih.gov/pubmed/27999202
http://dx.doi.org/10.18632/oncotarget.13980

Ejemplares similares